ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DANIEL FINNEY P.A.-C

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,869Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 298

$359K Total Retail Price of All Prescriptions

Rank: 9 out of 298

772 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 772 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

13% of this provider’s 772 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 6,156 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 287 265 1 1
METFORMIN HCL 220 182 2 4
DICLOFENAC SODIUM 218 192 3 52
LEVOTHYROXINE SODIUM 209 193 4 2
SIMVASTATIN 194 188 5 3
PREDNISONE 184 161 6 23
HYDROCODONE-ACETAMINOPHEN 169 132 S3 7 5
HYDROCHLOROTHIAZIDE 138 129 8 9
ZOLPIDEM TARTRATE 136 119 9 23
OMEPRAZOLE 136 128 9 6
PRAVASTATIN SODIUM 136 113 9 16
AMLODIPINE BESYLATE 125 110 12 7
FUROSEMIDE 124 115 13 11
TRAMADOL HCL 103 96 14 19
PANTOPRAZOLE SODIUM 101 96 15 62
POTASSIUM CHLORIDE 98 88 16 42
CITALOPRAM HBR 97 90 17 17
AZITHROMYCIN 93 85 18 28
ATENOLOL 91 88 19 15
MELOXICAM 84 81 20 45
ATORVASTATIN CALCIUM 81 78 21 20
LOSARTAN POTASSIUM 72 69 22 38
METOPROLOL TARTRATE 71 67 23 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 52 24 57
TAMSULOSIN HCL 63 55 25 31
WARFARIN SODIUM 62 62 26 25
OXYCODONE-ACETAMINOPHEN 60 56 S2 27 13
FLUTICASONE PROPIONATE 60 55 27 22
AMOX TR-POTASSIUM CLAVULANATE 59 50 29 80
SERTRALINE HCL 59 35 29 32
SYNTHROID 59 57 29 71
CRESTOR 58 58 32 66
ALLOPURINOL 56 51 33 96
METOPROLOL SUCCINATE 54 46 34 33
GABAPENTIN 54 42 34 10
ALENDRONATE SODIUM 53 53 36 20
FLUOXETINE HCL 53 38 36 37
GLYBURIDE 53 51 R 36 54
LOVASTATIN 51 45 39 14
TRIAMCINOLONE ACETONIDE 50 45 40 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.